Litcius/Paper detail

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Sandro Pignata, Daniela Califano, D. Lorusso, Laura Arenare, Michele Bartoletti, Ugo De Giorgi, Claudia Andreetta, Carmela Pisano, Giovanni Scambia, Davide Lombardi, Alberto Farolfi, Saverio Cinieri, Anna Passarelli, V. Salutari, Claudia De Angelis, Chiara Mignogna, Domenico Priolo, Ettore Capoluongo, Stefano Tamberi, Giulia Scaglione, Valentina Arcangeli, Rossella De Cecio, Giosuè Scognamiglio, Filippo Greco, Anna Spina, M. Turinetto, Daniela Russo, Vittoria Carbone, Chiara Casartelli, Clorinda Schettino, Francesco Perrone

2024Annals of Oncology35 citationsDOIOpen Access PDF

Topics & Concepts

AvelumabMedicineImmunotherapyOncologyEndometrial cancerProfiling (computer programming)Internal medicineGynecologyCancerPembrolizumabOperating systemComputer scienceEndometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentCancer Immunotherapy and Biomarkers